Ami Ashariati Prayoga (2014) The New Treatment Of Immune Thrombocytopenic Purpura. In: Naskah Lengkap Surabaya Hematologi Onkologi Medik Update XII (Surabaya HOM-Update XII ). Departemen Ilmu Penyakit Dalam Fakultas Kedokteran UNAIR, Surabaya, pp. 11-17. ISBN 978-602-18710-2-7

	Text (Peer Review) The New Treatment of Immune.pdf Download (1MB)
	Text (Artikel) Artikel The New Treatment of Immune_compressed.pdf Download (1MB)

Abstract

Primary immune thrombocytopenia (ITP) is an acquired immune mediated disorder characterized by isolated thrombocytopenia, defined as a peripheral blood platelet count less than 150 x 109/L, and the absence of any underiying cause. In Europe, adult ITP has an incidence of 1.6 to 3.9 cases per 100.000 per year with increasing incidence with older age and equal for the sexes except in the mid-adult years (30-60 years), when the disease is more prevalent in women.

Item Type:	Book Section
Uncontrolled Keywords:	Treatment Immune Thrombocytopenic Purpura
Subjects:	R Medicine > R Medicine (General) R Medicine > RC Internal medicine
Divisions:	01. Fakultas Kedokteran > Ilmu Penyakit Dalam
Creators:	Creators NIM Ami Ashariati Prayoga NIDN0030095402
Depositing User:	arys fk
Date Deposited:	27 Jul 2020 02:40
Last Modified:	27 Jul 2020 02:40
URI:	http://repository.unair.ac.id/id/eprint/96208
Sosial Share:

Actions (login required)

View Item